An Italian drug board is set to approve sales of the abortion-inducing drug RU486 in the predominantly Roman Catholic country, a news report said Wednesday.
The Italian Pharmaceuticals Agency (AIFA) will announce the decision on Thursday, the daily La Repubblica reported.
After a process lasting nearly two years, AIFA will allow sales of the drug under the name Mifegyne.
A 1978 Italian law allows surgical abortion only.
Italian law also allows doctors to refuse to perform abortions as conscientious objectors -- an option used by some 70 percent of Italy's gynaecologists.